ANI Pharmaceuticals, Inc. (ANIP) is a publicly traded Healthcare sector company. As of October 12, 2026, ANIP trades at $73.64 with a market cap of $1.70B and a P/E ratio of 20.65. ANIP moved -0.35% today. Year to date, ANIP is -6.40%; over the trailing twelve months it is -18.61%. Its 52-week range spans $54.10 to $99.50. Analyst consensus is strong buy with an average price target of $106.75. Rallies surfaces ANIP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for ANIP combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $73.64 |
| Market Cap | $1.70B |
| P/E Ratio | 20.65 |
| EPS | $3.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.50 |
| 52-Week Low | $54.10 |
| Volume | 423 |
| Avg Volume | 0 |
| Revenue (TTM) | $883.37M |
| Net Income | $78.34M |
| Gross Margin | 0.00% |
8 analysts cover ANIP: 0 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $106.75.